Ticker archive · $REPL

$REPL Filing Signals & Market Reactions

Delayed, SEO-crawlable recaps of AI-scored catalysts for $REPL — including observed post-filing price moves. Live streaming stays exclusive to VIP.

? All delayed signals

$REPL

$REPL – Replimune Reports Commercial Launch of TUDRIQEV and Q2 Net Loss of $57.1M

Replimune Group, Inc.

2026-10-28 00:00:00 UTC · SEC_8K · All $REPL

?? Positive AI Sentiment (+3.0 / 10)

First patient delivery of TUDRIQEV achieved in October; over 15 institutions prescribing
Q2 net loss narrowed to $57.1 million vs. $83.1 million in prior-year period
Cash and equivalents rose to $307.8M, supported by $141.0M net offering proceeds

Unlock Live VIP Terminal & Telegram – €10/mo Original filing ?